Clinical Trial Update: Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing systemic safety of Flutiform pMDI, Fluticasone pMDI, and Beclometasone Autohaler in children aged 5 to <12 with mild persistent asthma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Asthma

Drugs mentioned

• Beclometasone Autohaler (beclomethasone)
• Fluticasone pMDI (fluticasone propionate)
• Flutiform pMDI (fluticasone propionate/formoterol)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Mild Persistent Asthma | Phase 2 | Status: COMPLETED